The benefits and risks of risk-adjustment in paediatric cardiac surgery by Pagel, C et al.
The beneﬁts and risks of
risk-adjustment in paediatric cardiac
surgery
Christina Pagel,1 Sonya Crowe,1 Katherine Brown,2 Martin Utley1
Outcomes following paediatric cardiac
surgery have long been the subject of clin-
ical, regulatory, media and public scrutiny.
There are several reasons for this. The
work is among the most technically chal-
lenging, resource intensive and emotion-
ally charged clinical activity undertaken.
In the UK, past events, public inquiries
and intentions to reduce the number of
centres performing this surgery provide a
rich source of back-stories and a level of
public awareness that make paediatric
cardiac surgery ripe for political comment
and productive journalism.
In this context, collection and open
reporting of outcome data at a national
level is as fraught with difﬁculties as it is
inescapable. Chief among these is a rea-
sonable expectation from the profession
that audit will be ‘fair’ to clinical teams.
This translates to a view that, in the
reporting of outcomes, account should be
taken of the hugely diverse set of diagno-
ses and comorbid conditions that patients
present with, the wide range of surgical
procedures performed, differences in case
mix between centres and the impact of
the relatively small numbers of patients on
what can reliably be inferred from data.
These characteristics of the specialty make
risk-adjustment in outcomes analysis
deemed essential, but they also make it
very difﬁcult to achieve.
Efforts in a number of countries to
collect standardised data on case mix and
outcomes for paediatric cardiac surgery
(including our own national audit in the
UK) have led to a shift from the use of
consensus-based risk stratiﬁcation tools
(eg, RACHS-11 and ARISTOTLE2) to risk
estimates based on empirical data, for
example, the STS-EACTS score.3 This has
subtly shifted how risk is conceived of.
Earlier subjective methods took account
of how intrinsically difﬁcult and complex
the operations were. Empirical methods
do not—they account for how successful
clinical teams are at getting patients
through their ﬁrst month after surgery.
We are part of the research team that
developed the empirical risk-adjustment
method used by the National Institute of
Cardiovascular Outcomes Research
(NICOR) in its comparative analyses of
UK centre outcomes in March and April
2013.4 The Partial Risk Adjustment in
Surgery (PRAiS) model5 6 was developed
for the purpose of in-house monitoring of
short term outcomes by clinical teams.7 In
discussing here the use of PRAiS in com-
parative audit, we hope to illustrate
several points important to the interpret-
ation of risk-adjusted outcomes in this
surgical specialty, and indeed other areas
of clinical practice.
The original version of PRAiS was devel-
oped using 10 years of UK national audit
data (2000–2010). While the UK is one of
only three countries with mandatory data
submission for national audit, and the data
completeness and quality were very high
for many data-ﬁelds, there are inevitable
problems in using an audit database for
research and then using that research for
audit. For instance, comorbidity data were
included in the model despite concerns
about data quality. Given that comorbidity
is clearly clinically relevant when consider-
ing the risk of a case, we hoped that its
inclusion in a risk model would drive up
standards of data completeness and quality.
Indeed, a positive development following
NICOR’s April 2013 report is that, in the
3 years’ worth of data (2009–2012) resub-
mitted to NICOR by UK centres, data com-
pleteness is markedly better than in the
initial dataset used to develop PRAiS. In
particular, the proportion of records with a
recorded comorbidity (excluding Down
syndrome) doubled from 15% to 30% of
cases. For this reason, and because of seem-
ingly improved raw survival rates since
2007–2010 and with the prospect of
further comparative analysis by NICOR, we
recalibrated the PRAiS model on this
most recent 2009–2012 dataset at
NICOR’s request (details of the current
calibration of PRAiS will always be available
on: http://www.ucl.ac.uk/operational-research/
AnalysisTools/PRAiS).
While we are proud of PRAiS and think
it ﬁt for the purpose of in-house monitor-
ing, it is important to remember that a
major pitfall in risk-adjustment is believing
one has completely adjusted for risk. All
clinical risk models can only partially
account for risk and this must be borne in
mind when interpreting risk-adjusted
outcome data. Inevitably, some factors
associated with risk of 30-day mortality
are not accounted for in PRAiS (how many
we do not know) and others are not
accounted for fully. For example, given his-
torically poor data quality, non-Down’s
comorbidities are treated equally within
PRAiS, although intuitively clinicians are
aware that some conditions are more
adverse (eg, extreme vs non-extreme pre-
maturity). Using PRAiS within a single
centre, one can assume that the prevalence
of factors not accounted for is relatively
stable and that medium–long term changes
(say a rise in the proportion of patients
with extreme prematurity) would be
recognised and understood by the local
clinical team. If comparing PRAiS-adjusted
outcomes between centres, one needs to
recognise that case mix in terms of factors
unaccounted for in the model may differ.
Although partial risk-adjustment makes for
fairer comparisons, it does not make com-
parisons fair.
In many audits, including the work of
NICOR, risk-adjusted outcomes are put in
the context of a funnel plot of prediction
limits (often set to report 95% or 99.8%
prediction intervals). It should always be
remembered that observed outcomes may
lie outside a prediction interval for one or
more of a number of reasons including:
data completeness and quality; aspects of
case mix not accounted for in the risk
model; changes in the underlying risks of
surgery since the model was calibrated; a
chance run of better or worse than pre-
dicted outcomes; or markedly better or
worse than ‘average’ team performance.
Although the notion of chance playing a
role in determining programme-level out-
comes is often unpalatable to clinical
teams, it is central to the statistical inter-
pretation of these data using tools such as
prediction intervals and funnels. If one
accepts the role of chance, presenting out-
comes from multiple centres in the context
of a prediction interval makes interpret-
ation of outcomes that fall outside the
interval even more complicated. Imagine
throwing a coin four times in a row. The
chance of you getting four heads in a row
is about 6%. Now imagine 10 of your
friends each throwing a coin four times in
a row. There is almost a 50% chance that
at least one of them would throw four
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heads, but importantly you would not
know which friend(s) in advance. Just as it
would make little sense to assume that any
of your friends that got four heads is par-
ticularly good at achieving heads, in the
absence of other information a single unit
out of 10 being outside a 95% funnel is
not evidence of especially good or poor
performance. Indeed, if one accepts the
role of chance in determining outcomes,
there is about a 40% chance that at least
one unit out of 10 will be outside its 95%
prediction interval.
However fair or unfair, comparisons do
have a role to play in quality assurance and
quality improvement. In many areas of
healthcare there are no absolute standards
and so feedback in terms of outcomes has
to rely on the relative standards of ‘how
are we doing compared with last year?’
and ‘how are we doing compared with the
place down the road?’ If comparisons are
made in the spirit of improvement and
with an understanding of the caveats, there
is valuable learning to be had that could
lead to improved outcomes. The approach
taken by Queensland Health in Australia in
their quality improvement programme8
was to set quite a low threshold for a ‘ﬂag’
so that most programmes went through
the incremental process of review every
now and then, with the result that any
stigma soon faded. Such an approach is
compatible with a ‘safety ﬁrst’ governance
ethos with an expectation that genuine
problems would likely be identiﬁed and
addressed in a timely way. Importantly, this
was coupled with a sensible protocol for
response that began with a review of the
data concerned. Any further investigation
proceeded as far as warranted through an
ordered sequence of additional reviews
(looking next at the patient case mix, then
the health service structure and resources,
followed by healthcare processes and
ﬁnally professional performance).
Focusing only on comparative analysis
and relative outcomes misses the wider
context of changes in absolute outcomes.
Completely missing from the media debate
in the spring of 2013 was the fact that
30-day survival following paediatric heart
surgery in the UK is among the highest in
the world (currently greater than 97%,
NICOR4) and has improved steadily since
the 1990s. What was miraculous a gener-
ation ago is now deemed a minimum
standard. This highlights the importance
of periodic recalibration of any risk model
to incorporate the continuous evolution of
practice and improving outcomes.
Finally, use of 30-day survival suits
timely in-house monitoring, which moti-
vated the development of PRAiS.
However, we must not forget that for
many children and their families, the
experience of congenital heart disease con-
tinues beyond 30 days. Many congenital
heart conditions require several staged sur-
geries and all operated children require
long term follow-up. The clinical intent in
treating patients is to secure long term sur-
vival and improved quality of life for
patients rather than 30-day survival. For
this reason, national audit of 30-day out-
comes should only ever be part of a larger
programme of quality assurance and
improvement, focused on delivering the
best possible long term outcomes.
Correction notice This paper has been corrected
since it was ﬁrst published online.
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